At World Sleep Congress 2025, BMC Showcases Smarter Sleep Solutions: G3 APAP and Digital Health for Everyday Life

With obstructive sleep apnea (OSA) becoming a major global health concern, BMC Medical took center stage to showcase how smart, connected therapies represent the future of respiratory care at the World Sleep Congress 2025 in Singapore, through G3 APAP and Digital Health Solution.

Tackling the Global OSA Challenge and BMC’s Vision at World Sleep 2025

Obstructive sleep apnea (OSA) is among today’s most pressing global health challenges, leaving millions with poor sleep quality, daytime fatigue, and serious health risks. As awareness rises, intelligent, digitally connected therapies are increasingly essential. 

Against this backdrop, the World Sleep Congress 2025 in Singapore—organized by the World Sleep Society to advance sleep health worldwide—served as a leading international forum for science and clinical exchange, uniting global experts to foster collaboration. 

For BMC Medical, the congress wasn’t just an event—it was a chance to connect with the global sleep community and share what truly matters: making respiratory care more effective, more comfortable, and more personalized. It offered a meaningful moment to show how BMC is rethinking the CPAP experience—making it smarter, easier to use, and more in tune with real patients’ needs.

G3 and PAP Link: An Integrated Ecosystem of Smart Devices and Digital Health

At WSC 2025, BMC presented CPAP devices, masks and the digital health solution platform. The G3 APAP and the PAP Link platform stood out as the core highlights.

The G3 APAP is designed to adapt to each person’s unique breathing patterns, using intelligent pressure adjustment and 100% central apnea detection to deliver personalized, comfortable therapy every night. Its built-in Hidden Doctor Assistant algorithm learns and adjusts over time, helping users stay on track with long-term treatment—without constant manual tweaking.

Meanwhile, the PAP Link digital platform puts real-time insights directly into users’ hands. From daily sleep reports to progress tracking and helpful coaching tips, it transforms what could be a complex therapy into something intuitive and manageable. Whether users are at home, traveling, or adjusting to therapy for the first time, PAP Link keeps them informed, supported, and in control.

Together, these products and services underscore BMC’s commitment to advancing a complete ecosystem—from devices to digital health—that simplifies and digitalizes care, supports clinicians with greater efficiency, and empowers patients with smarter, more patient-friendly solutions.

Engaged Interactions, Expert Workshops, and Shared Values

At the World Sleep Congress 2025, BMC’s booth was alive with activity. Doctors engaged in discussions with BMC experts to learn about the innovative devices. Many doctors and physicians joined photo check-in activity under the shared belief of “Breathe Easy Sleep Well”.

BMC also convened a workshop titled “Detecting All Central Events Using CPAP – What’s the Point?” to address whether CPAP should routinely detect central hypopneas alongside central apneas. The session explored how accurate detection affects residual AHI tracking, adherence, and treatment pathways, while also weighing risks such as misclassification and added workload, emphasized the importance of balanced, evidence-based evaluation. 

The workshop reflected a broader commitment: ensuring technology choices not only address technical debates but also translate into tangible benefits for both patients and clinicians. For patients, this translates into greater comfort, stronger adherence, and improved quality of life; for clinicians, it means lighter follow-up demands and greater efficiency in care delivery. The message was clear: BMC is advancing not just devices, but also professional dialogue that improves therapy outcomes and strengthens trust with patients and clinicians alike.

BMC team photo at the WSC 2025.

“Breathe Easy, Sleep Well” check-in activity at BMC booth during WSC 2025.

BMC’s workshop at WSC 2025: “Detecting All Central Events Using CPAP – What’s the Point?”

Expert and User Voices: Precision Monitoring Meets Real-Life Benefits

Experts emphasized the importance of accurate detection of all central sleep events. Based on clinical data and complex patient cases, they recognized that precise monitoring is crucial for effective therapy and patient safety. 

Dr. Renata L Riha noted, “We need devices that don’t just detect central apneas, but capture them reliably to guide targeted therapy.” Dr. Renata L Riha highlighted that accurate central event monitoring can significantly influence therapy pathways and patient outcomes. The G3’s 100% central apnea detection, intelligent pressure algorithms, combined with the remote monitoring capabilities of PAP Link, provide clinicians with reliable central apnea capture. 

This ensures that the clinical insights emphasized by Dr. Riha are effectively translated into practice, allowing patients to receive consistent and targeted treatment. It demonstrates that the technology not only meets rigorous clinical standards but also delivers practical, patient-centered care.

For users, the difference is personal and immediate. Asnita, a CPAP user from Australia, shared her experience: “The G3 adjusts so smoothly to my breathing that I barely notice it. It’s quiet, comfortable, and I can check my sleep data anytime from my phone. It’s like my breathing is in the cloud—I wake up feeling recharged.”

Stories like Asnita’s reflect the broader impact of smart, connected therapy. People reported sleeping through the night more consistently, waking with more energy, and feeling more in control of their treatment. For frequent travelers or those with irregular routines, the ability to monitor progress remotely provided a sense of stability and reassurance.

In short, BMC’s solutions are closing the gap between clinical precision and daily usability. Experts trust the data, and users feel the difference. It’s technology that not only meets medical standards—but also fits into real lives.

                                                                                Dr. Renata L Riha speaking at BMC’s WSC 2025 workshop

                                                                  Australian user Asnita enjoys restful sleep with the G3 A20 CPAP.

Global Recognition and Certification: Safe, Reliable, and Trusted

The confidence shown by patients and experts alike is rooted in BMC’s strong foundation of safety and reliability. All devices showcased by BMC at WSC 2025 are CE-certified. Available in over 180+ countries/regions , BMC ranked No. 2 worldwide and No. 1 in China in CPAP sales, as of August 2024. BMC products meet rigorous international safety and quality standards, reinforcing the company’s reputation as a trusted partner in global respiratory care.

Innovation and Patient-Centered Care: Breathing Easier, Sleeping Better

BMC’s presence at the World Sleep Congress 2025 highlighted how innovation and patient-centered design can redefine CPAP therapy. From the clinical accuracy of the G3 to the connectivity of PAP Link, BMC is building a future where patients breathe easier, sleep better, and live healthier. Beyond patients and clinicians, its ecosystem eases the burden on families with convenient health tracking, while helping healthcare systems simplify pathways, improve efficiency, and reduce overall costs. 

BMC’s vision is clear: to become the first choice in respiratory care by offering solutions that improve adherence, enhance comfort, and integrate seamlessly into everyday life. With innovation and care at its core, BMC continues to help families worldwide Breathe Easy, Sleep Well.